Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNWIND: Exercise vs Lexapro for Anxiety in CHD
NCT02516332Completed
- Sponsor
- Duke University
- Start
- Dec 2015
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of escitalopram in anxiety disorder (3 arms), sponsored by Duke University. Primary endpoint: Change in Hospital Anxiety and Depression Scale, Anxiety at 3 months. Started Dec 2015; status: completed.
02
Drugs
escitalopram
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT02516332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02516332.